Vir Biotechnology at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Vir Biotechnology brings 2 presentations to PEGS Europe 2026 in Lisbon. Its contribution covers masked T cell engagers that switch on only where tumour proteases cut the mask, sparing healthy tissue and limiting toxicity.

OrganizationPEGS Europe 2026 Attendance
Vir Biotechnology
San Francisco, CA
vir.bio
Biotech
Biotech developing treatments for infectious disease and cancer, including masked T cell engagers designed to activate inside tumours.
Talk
Tue Nov 17
11:15am–11:45am
Chair
Tue Nov 17
2:00pm–2:05pm
Chairperson's Remarks
T Cell Engagers · with Molecular Partners

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Vir Biotechnology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction